Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence
Magna Scientia Advanced Research and Reviews · 31.08.2026 · 17 (2) · 430-433
DOI: 10.30574/msarr.2026.17.2.0147 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Magna Scientia Advanced Research and Reviews, online erschienen am 31.08.2026. Verfasst von Fanny Fanny und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Although Lansium domesticum Corrêa is widely used in Southeast Asian traditional medicine, its phytochemical diversity and antioxidant activity cannot be considered definitive evidence of antimalarial efficacy. A rigorous synthesis is required to distinguish specific anti-parasitic findings from data that only informs chemical characteristics or host-cell safety.
Objective
This review aims to critically synthesize 17 species-specific primary studies published between 2016 and 2026 to differentiate direct antiplasmodial evidence from translational-enabling data.
Methods
This systematic review was prospectively registered in PROSPERO (CRD420261458422). Systematic searches through July 2026 targeted studies reporting malaria-related endpoints. Evidence was classified as direct (whole-parasite assays, infected-animal models, or parasite-specific targets) or translational-enabling (phytochemical characterization, safety, or mechanistic evidence). Findings were synthesized narratively in accordance with the PRISMA 2020 statement and the Synthesis Without Meta-analysis (SWiM) reporting guideline.
Results
Seventeen studies were identified: four provided direct evidence and 13 were enabling. Root chloroform and methanol fractions exhibited potent in vitro inhibition (IC50 1.4–3.6 µg/mL), yet in vivo stem-bark data showed a non-monotonic response and a high risk of bias. A significant unit discrepancy (mg/mL vs. µg/mL) was identified in reports for dukunolides, and in silico docking results lack experimental confirmation. Currently, no lead candidate possesses matched parasite-host selectivity, standardized chemistry, or pharmacokinetic data.
Conclusion
Lansium domesticum is currently a source of preclinical leads rather than a validated antimalarial medicine. Future research must prioritize unit verification, standardized same-batch selectivity testing, mechanism validation, and rigorously controlled animal studies.
Zitieren
APA
Fanny, F., Ningtiyas, S. A., & Sinulingga, S. (2026). Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence. Magna Scientia Advanced Research and Reviews, 17(2), 430-433. https://doi.org/10.30574/msarr.2026.17.2.0147
Vancouver
Fanny F, Ningtiyas SA, Sinulingga S. Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence. Magna Scientia Advanced Research and Reviews. 2026;17(2):430-433. doi:10.30574/msarr.2026.17.2.0147
BibTeX
@article{Fanny2026,
author = {Fanny, Fanny and Ningtiyas, Salwa Adilah and Sinulingga, Sadakata},
title = {Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence},
journal = {Magna Scientia Advanced Research and Reviews},
year = {2026},
volume = {17},
number = {2},
pages = {430--433},
doi = {10.30574/msarr.2026.17.2.0147}
}
EUVIMED